Balance Sheet for Arena Pharmaceuticals Inc. (ARNA)

$ 50.63   -0.56 (-1.09%) Volume: 138.9k 10:37 AM EDT 20-Sep-2019
Statement: View:
Assets [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Cash and Equivalents 161,037 158,837 90,712 156,184 163,209
Restrictable Cash - - - - -
Marketable Securities 284,594 88,240 - - 71,547
Accounts Receivable 5,086 2,357 573 4,934 3,712
Loans Receivable - - - - -
Other Receivables 12,025 12,025 - - -
Receivables 5,086 14,382 573 4,934 3,712
Inventories, Raw Materials - 8,508 2,553 2,487 1,167
Inventories, Work in Progress - 10,626 3,943 2,781 3,520
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - 1,827 212 4,234 6,144
Inventories, Other - 20,961 6,708 9,502 10,831
Inventories, Adjustments & Allowances - - - - -
Inventories - 20,961 6,708 9,502 10,831
Prepaid Expenses 10,008 2,681 2,169 4,218 4,144
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 460,725 281,280 119,889 174,838 181,896
Land and Improvements 4,950 7,650 7,650 8,131 11,339
Buildings and Improvement 60,161 72,353 72,353 92,688 92,613
Machinery, Furniture and Equipment 4,431 8,241 19,634 71,910 70,986
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 69,542 88,244 99,637 172,729 174,938
Gross Fixed Assets 69,542 88,244 99,637 172,729 174,938
Accumulated Depreciation (46,428) (58,113) (64,528) (100,901) (92,019)
Net Fixed Assets 23,114 30,131 35,109 71,828 82,919
Intangibles - - 2,357 7,775 8,482
Cost in Excess - - - - -
Non-Current Deferred Income Taxes 110,333 - - - -
Other Non-Current Assets 10,319 3,622 14,012 2,351 3,088
Total Non-Current Assets 226,178 57,995 49,121 81,954 94,489
Total Assets 686,903 339,275 169,010 256,792 276,385
Liabilities [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Accounts Payable 6,192 1,599 1,295 14,158 34,766
Short Term Debt 3,283 4,000 3,518 2,978 2,492
Notes Payable - - - - -
Accrued Expenses 11,821 32,768 4,561 6,217 9,600
Accrued Liabilities 11,821 32,768 4,561 6,217 9,600
Deferred Revenues - 1,110 4,410 21,425 15,238
Current Deferred Income Taxes (110,333) - - - -
Other Current Liabilities 8,622 32,850 50,095 5,118 5,266
Total Current Liabilities 29,918 72,327 63,879 49,896 67,362
Long Term Debt 49,426 57,748 61,748 65,267 68,245
Deferred Income Tax - 1,067 2,167 87,617 93,433
Other Non-Current Liabilities 1,301 2,811 2,988 88,087 93,433
Minority Interest - (755) 491 - -
Capital Lease Obligations 49,426 57,748 61,748 65,267 68,245
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 50,727 59,804 65,227 153,354 161,678
Total Liabilities 80,645 132,131 129,106 203,250 229,040
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 606,258 207,144 39,904 53,542 47,345
Common Par 5 4 2 24 22
Additional Paid in Capital 2,106,960 1,698,543 1,441,737 1,430,917 1,312,656
Cumulative Translation Adjustments - - - - -
Retained Earnings (1,500,552) (1,490,187) (1,398,736) (1,376,220) (1,268,241)
Treasury Stock - - - - -
Other Equity Adjustments (155) (1,216) (3,099) (1,179) 2,908
Total Capitalization 606,258 207,144 39,904 53,542 47,345
Total Equity 606,258 207,144 39,904 53,542 47,345
Total Liabilities & Shareholder's Equity 686,903 339,275 169,010 256,792 276,385
Cash Flow (32,494) (92,732) (33,449) (105,185) (60,371)
Working Capital 430,807 208,953 56,010 124,942 114,534
Free Cash Flow (132,904) (66,755) (63,089) (109,105) (110,303)
Invested Capital 606,258 207,144 39,904 53,542 47,345
Shares Outstanding - Common Class Only 49,423 39,281 24,340 24,287 22,032
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 49,423 39,281 24,340 24,287 22,032
Total Common Shares Outstanding 49,423 39,281 24,340 24,287 22,032
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 47,041 32,990 24,313 24,067 21,973
Diluted Weighted Shares Outstanding 47,041 32,990 24,313 24,067 21,973